Package 82009-161-94

Brand: ustekinumab-ttwe

Generic: ustekinumab-ttwe
NDC Package

Package Facts

Identity

Package NDC 82009-161-94
Digits Only 8200916194
Product NDC 82009-161
Product ID 82009-161_cb6d8d30-9458-42ed-8aee-2aae13f4760b
Description

.5 mL in 1 VIAL (82009-161-94)

Marketing

Marketing Status
Marketed Since 2026-02-15
Brand ustekinumab-ttwe
Generic ustekinumab-ttwe
Sample Package No

Linked Drug Pages (1)

USTEKINUMAB-TTWE ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["SUBCUTANEOUS"], "spl_id": "cb6d8d30-9458-42ed-8aee-2aae13f4760b", "openfda": {"nui": ["N0000192797", "N0000192796", "N0000192799", "N0000192798"], "unii": ["FU77B4U5Z0"], "rxcui": ["2705557", "2705568", "2705575", "2713885"], "spl_set_id": ["2b34392a-ecf6-41bd-8706-d4e9f0b25da8"], "pharm_class_epc": ["Interleukin-12 Antagonist [EPC]", "Interleukin-23 Antagonist [EPC]"], "pharm_class_moa": ["Interleukin-12 Antagonists [MoA]", "Interleukin-23 Antagonists [MoA]"], "manufacturer_name": ["Quallent Pharmaceuticals Health LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": ".5 mL in 1 VIAL (82009-161-94)", "package_ndc": "82009-161-94", "marketing_start_date": "20260215"}], "brand_name": "USTEKINUMAB-TTWE", "product_id": "82009-161_cb6d8d30-9458-42ed-8aee-2aae13f4760b", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Interleukin-12 Antagonist [EPC]", "Interleukin-12 Antagonists [MoA]", "Interleukin-23 Antagonist [EPC]", "Interleukin-23 Antagonists [MoA]"], "product_ndc": "82009-161", "generic_name": "ustekinumab-ttwe", "labeler_name": "Quallent Pharmaceuticals Health LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "USTEKINUMAB-TTWE", "active_ingredients": [{"name": "USTEKINUMAB", "strength": "45 mg/.5mL"}], "application_number": "BLA761373", "marketing_category": "BLA", "marketing_start_date": "20250415", "listing_expiration_date": "20271231"}